phosphoramidic acid has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, AT; Davey, MS; Le Duff, CS; Malde, R; Mehellou, Y; Mykura, RC; Taher, TE; Willcox, BE | 1 |
| Dikmen, ZG; Gryaznov, SM; Shay, JW; Wright, WE | 1 |
2 other study(ies) available for phosphoramidic acid and Bladder Cancer
| Article | Year |
|---|---|
Synthesis and Biological Evaluation of ( E)-4-Hydroxy-3-methylbut-2-enyl Phosphate (HMBP) Aryloxy Triester Phosphoramidate Prodrugs as Activators of Vγ9/Vδ2 T-Cell Immune Responses.
Topics: Amides; Cells, Cultured; Humans; Immunotherapy; Lymphocyte Activation; Organophosphates; Phosphoric Acids; Prodrugs; Receptors, Antigen, T-Cell, gamma-delta; T-Cell Antigen Receptor Specificity; T-Lymphocyte Subsets; Urinary Bladder Neoplasms | 2018 |
Telomerase targeted oligonucleotide thio-phosphoramidates in T24-luc bladder cancer cells.
Topics: Amides; Antineoplastic Agents; Cell Line, Tumor; Humans; Oligonucleotides; Oligopeptides; Phosphoric Acids; RNA; Telomerase; Urinary Bladder Neoplasms | 2008 |